Home > Healthcare > Medical Devices > Medical Supplies > Biosensors Market

Biosensors Market Share

Report ID: GMI747
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Biosensors Market Share

The global market is highly competitive and rapidly evolving, driven by advancements in sensor technologies, the increasing demand for real-time health monitoring, and a shift towards personalized medicine. Major players such as Abbott Laboratories and Roche dominate the landscape, while emerging companies are pushing the boundaries of innovation through strategic partnerships and new product developments. As the market expands, competition is intensifying, especially in regions like North America and Asia Pacific, where technological adoption and healthcare expenditures are growing significantly.

Biosensors Market Companies

Some of the eminent market participants operating in the biosensors industry include:

Abbott Laboratories
Ascensia Diabetes Care Holdings
Bio-Rad Laboratories
Biosensors International Group
Danaher Corporation
Dexcom
F. Hoffmann-La Roche
LifeScan
Masimo
Nova Biomedical
Pinnacle Technology
QTL Biosystems
Siemens Healthineers
TE Connectivity Corporation
Thermo Fisher Scientific

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global biosensors industry was valued at approximately USD 30.1 billion in 2023 and is estimated to grow at a 7.7% CAGR from 2024 to 2032, driven by the rising global prevalence of diabetes.

The non-wearable biosensors segment held a substantial 64.2% market share in 2023 due to their ease of use, high accuracy, and rapid diagnostic capabilities.

The point-of-care testing (POC) segment is projected to reach USD 29.8 billion by 2032, as biosensors in POC testing provide quick results, crucial for acute conditions and emergencies.

Key players in the industry include Abbott Laboratories, Ascensia Diabetes Care Holdings, Bio-Rad Laboratories, Biosensors International Group, Danaher Corporation, Dexcom, F. Hoffmann-La Roche, LifeScan, Masimo, and Nova Biomedical.